Literature DB >> 26131289

Comparison of peripheral blood T lymphocyte immune function among venous thromboembolism patients with and without infection and patients with simple infection.

Lin Zhou1, Yu Mao1, Lemin Wang1, Jinfa Jiang1, Wenjun Xu1, Jiahong Xu1, Haoming Song1.   

Abstract

OBJECTIVE: To investigate the differences of T lymphocyte subgroups and high-sensitivity C reactive protein (HsCRP) levels among patients with venous thromboembolism (VTE), VTE patients with infection, simple infection patients and the normal controls.
METHOD: 289 patients were enrolled in this study and divided into control group, VTE group, VTE with infection group and simple infection group. RESULT: Compared with the control group, the serum levels of CD3(+), CD4(+), CD8(+) T lymphocytes significantly decreased and CD4(+)/CD8(+) ratio significantly increased in simple infection group (P < 0.05); CD3(+) and CD8(+) T lymphocytes significantly decreased and CD4(+)/CD8(+) ratio significantly increased in VTE and VTE with infection group (P < 0.05); the proportion of declined CD3(+) and CD8(+) T lymphocytes increased, and the proportion of increased CD4(+)/CD8(+) ratio statistically elevated in three disease groups. As an important inflammatory factor, all HsCRP levels in three disease groups significantly increased when compared with the control group.
CONCLUSION: Immune dysfunction exists in both of VTE and infection patients, while VTE patients tend to be accompanied with infections. The changes of T lymphocyte subgroups in VTE patients, who were independent from infection, could cause T lymphocyte immune dysfunction, suggesting that there were abnormalities of T lymphocyte immune function in VTE itself. The overall T lymphocyte functions of recognizing antigens and transducing activation signals decline in VTE patients. Besides, the function of T lymphocyte of directly killing virus microbes declines significantly and the inflammatory mechanisms are involved in the occurrence and development of venous thrombosis.

Entities:  

Keywords:  T lymphocyte; immune function; venous thromboembolism

Year:  2015        PMID: 26131289      PMCID: PMC4483919     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

Review 1.  Incidence of diagnosed deep vein thrombosis in the general population: systematic review.

Authors:  F J I Fowkes; J F Price; F G R Fowkes
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-01       Impact factor: 7.069

2.  Severe acute respiratory syndrome and venous thromboembolism in multiple organs.

Authors:  Yi Xiang-Hua; Wang Le-Min; Liang Ai-Bin; Gong Zhu; Lai Riquan; Zhu Xu-You; Rui Wei-Wei; Wang Ye-Nan
Journal:  Am J Respir Crit Care Med       Date:  2010-08-01       Impact factor: 21.405

3.  Compromised T-cell immunity and virus-like structure in a patient with pulmonary hypertension.

Authors:  Lemin Wang; Zhu Gong; Aibin Liang; Yuan Xie; Shu-Lin Liu; Zhang Yu; Ling Wang; Yenan Wang
Journal:  Am J Respir Crit Care Med       Date:  2010-08-01       Impact factor: 21.405

Review 4.  Pulmonary thromboembolism: overview and update from medicolegal aspects.

Authors:  Ayako Ro; Norimasa Kageyama; Takanobu Tanifuji; Tatsushige Fukunaga
Journal:  Leg Med (Tokyo)       Date:  2007-11-26       Impact factor: 1.376

5.  T cell-mediated immune deficiency or compromise in patients with CTEPH.

Authors:  Song Haoming; Wang Lemin; Gong Zhu; Liang Aibin; Xie Yuan; Lv Wei; Jiang Jinfa; Xu Wenjun; Shen Yuqin
Journal:  Am J Respir Crit Care Med       Date:  2011-02-01       Impact factor: 21.405

Review 6.  Deep vein thrombosis.

Authors:  Paul A Kyrle; Sabine Eichinger
Journal:  Lancet       Date:  2005 Mar 26-Apr 1       Impact factor: 79.321

7.  Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.

Authors:  Thomas R Meier; Daniel D Myers; Shirley K Wrobleski; Paul J Zajkowski; Angela E Hawley; Patricia W Bedard; Nicole E Ballard; Frank J Londy; Neelu Kaila; George P Vlasuk; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

8.  mRNA expression of interleukins and Th1/Th2 imbalance in patients with pulmonary embolism.

Authors:  Qianglin Duan; Wei Lv; Lemin Wang; Zhu Gong; Qiang Wang; Haoming Song; Hao Wang
Journal:  Mol Med Rep       Date:  2012-10-23       Impact factor: 2.952

9.  Acute infections and venous thromboembolism.

Authors:  M Schmidt; E Horvath-Puho; R W Thomsen; L Smeeth; H T Sørensen
Journal:  J Intern Med       Date:  2011-12-08       Impact factor: 8.989

10.  Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting.

Authors:  Liam Smeeth; Claire Cook; Sara Thomas; Andrew J Hall; Richard Hubbard; Patrick Vallance
Journal:  Lancet       Date:  2006-04-01       Impact factor: 79.321

View more
  1 in total

1.  Clinical characteristics and risk factors predictive of pulmonary embolism complicated in bronchiectasis patients: a retrospective study.

Authors:  Tiantian Deng; Ke Xu; Beishou Wu; Fei Sheng; Xu Li; Zhuxian Zhu; Ziqiang Zhang
Journal:  BMC Pulm Med       Date:  2022-06-09       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.